Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

However, significant negative correlations were found between LDH levels and PedMQLS emotional scale (r = -0,42; p = 0,020), between tryptase levels and CDLQI (r = -0,37; p = 0,039), between vitamin D levels and PedMQLS emotional (r = -0,36; p = 0,045) and total scales (r = -0,37; p = 0,038).

Source: Known-groups validity. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Children aged to 6 to 18 years: diagnosed with cutaneous mastocytosis and followed in outpatient clinics of Pediatric Allergy and Immunology in Prof.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Development and validation of a quality of life scale for pediatric mastocytosis

Study design awaiting verification · Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology · 2026

Original publication title

Development and validation of a quality of life scale for pediatric mastocytosis

Aslı Berivan Topçak; Ece Tüsüz Önata; Şeyma Genç; Sefika Ilknur Kökcü Karadag; Nilay Çalışkan; Güler Yıldırım; Hamit Boloğur; Hilal Güngör; Merve Karaca Şahin; Muhammed Fatih Erbay; Hasan Tunç Şarman; Özlem Terzi; Emek Kocatürk; Frank Siebenhaar; Öner Özdemir; Deniz Özçeker

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These newly developed scales are the first validated quality of life instruments specific for pediatric mastocytosis. This study is preliminary; validation through multicenter studies with larger sample.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aimed to develop and validate two disease-specific quality of life instruments: the Pediatric Mastocytosis Quality of Life (PedMQLS) and the Pediatric Mastocytosis Quality of Life: Parent (PedParentMQLS) scales: for use in pediatric mastocytosis.

Source: Objective

Abstract: What methods does the paper describe?

A total of 51 children and their parents were recruited from two specialized tertiary centers in Turkey. Scale items were generated based on expert opinion and literature review. Content validity was evaluated using the Davis method, and construct validity was assessed through exploratory factor analysis (EFA). Internal consistency was measured using Cronbach’s alpha, and convergent validity was examined by correlating results with established dermatology-specific quality of life instruments.

Source: Methods

Abstract: Results

Both scales consisted of 14 items and revealed a two-factor structure covering social and emotional domains. Pediatric Mastocytosis Quality of Life-Parent Scale showed high internal consistency (α = 0.909), while the Pediatric Mastocytosis Quality of Life Scale demonstrated acceptable reliability (α = 0.785). Significant correlations with comparable instruments supported the scales’ convergent validity.

Source: Results

Abstract: Conclusion

These newly developed scales are the first validated quality of life instruments specific for pediatric mastocytosis. This study is preliminary; validation through multicenter studies with larger sample.

Source: Conclusion
Authors’ abstract

Background

Mastocytosis imposes a considerable burden on patients’ quality of life. While validated QoL instruments are available for adults with systemic mastocytosis, no disease-specific quality-of-life measure has yet been developed for pediatric populations.

Objective

This study aimed to develop and validate two disease-specific quality of life instruments: the Pediatric Mastocytosis Quality of Life (PedMQLS) and the Pediatric Mastocytosis Quality of Life: Parent (PedParentMQLS) scales: for use in pediatric mastocytosis.

Methods

A total of 51 children and their parents were recruited from two specialized tertiary centers in Turkey. Scale items were generated based on expert opinion and literature review. Content validity was evaluated using the Davis method, and construct validity was assessed through exploratory factor analysis (EFA). Internal consistency was measured using Cronbach’s alpha, and convergent validity was examined by correlating results with established dermatology-specific quality of life instruments.

Results

Both scales consisted of 14 items and revealed a two-factor structure covering social and emotional domains. Pediatric Mastocytosis Quality of Life-Parent Scale showed high internal consistency (α = 0.909), while the Pediatric Mastocytosis Quality of Life Scale demonstrated acceptable reliability (α = 0.785). Significant correlations with comparable instruments supported the scales’ convergent validity.

Conclusion

These newly developed scales are the first validated quality of life instruments specific for pediatric mastocytosis. This study is preliminary; validation through multicenter studies with larger sample.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13223-026-01051-z.

Publication and source details

Original title: Development and validation of a quality of life scale for pediatric mastocytosis

Aslı Berivan Topçak; Ece Tüsüz Önata; Şeyma Genç; Sefika Ilknur Kökcü Karadag; Nilay Çalışkan; Güler Yıldırım; Hamit Boloğur; Hilal Güngör; Merve Karaca Şahin; Muhammed Fatih Erbay; Hasan Tunç Şarman; Özlem Terzi; Emek Kocatürk; Frank Siebenhaar; Öner Özdemir; Deniz Özçeker

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Charité: Universitätsmedizin Berlin (3093)

Open Access funding enabled and organized by Projekt DEAL.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:05:37.411426+00:00

DOI: 10.1186/s13223-026-01051-z · PMC13386695